Opioid-induced constipation: advances and clinical guidance

被引:78
|
作者
Nelson, Alfred D. [1 ]
Camilleri, Michael [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Clin Enter Neurosci Translat & Epidemiol Res CENT, Charlton Bldg,Room 8-110,200 First St SW, Rochester, MN 55905 USA
关键词
lubiprostone; methylnaltrexone; naloxegol; noncancer pain; peripheral mu opioid receptor antagonist; tolerance; CHRONIC NONCANCER PAIN; PROLONGED-RELEASE OXYCODONE; INDUCED BOWEL DYSFUNCTION; PLACEBO-CONTROLLED TRIAL; QUATERNARY NARCOTIC-ANTAGONISTS; RECOMBINANT HUMAN CLC-2; DOUBLE-BLIND; HEALTHY-VOLUNTEERS; SUBCUTANEOUS METHYLNALTREXONE; GASTROINTESTINAL TRANSIT;
D O I
10.1177/2040622315627801
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Currently opioids are the most frequently used medications for chronic noncancer pain. Opioid-induced constipation is the most common adverse effect associated with prolonged use of opioids, having a major impact on quality of life. There is an increasing need to treat opioid-induced constipation. With the recent approval of medications for the treatment of opioid-induced constipation, there are several therapeutic approaches. This review addresses the clinical presentation and diagnosis of opioid-induced constipation, barriers to its diagnosis, effects of opioids in the gastrointestinal tract, differential tolerance to opiates in different gastrointestinal organs, medications approved and in development for the treatment of opioid-induced constipation, and a proposed clinical management algorithm for treating opioid-induced constipation in patients with noncancer pain.
引用
收藏
页码:121 / 134
页数:14
相关论文
共 50 条
  • [1] Advances in pharmacotherapy for opioid-induced constipation - a systematic review
    Siemens, Waldemar
    Gaertner, Jan
    Becker, Gerhild
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 515 - 532
  • [2] Opioid-induced constipation
    Plaisance, L
    Ellis, JA
    AMERICAN JOURNAL OF NURSING, 2002, 102 (03) : 72 - 73
  • [3] Opioid-induced Constipation
    Vallerand, April Hazard
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2017, 13 (02): : 170 - 174
  • [4] Opioid-induced constipation
    Gyawali, Bishal
    Hayashi, Naomi
    Tsukuura, Hiroaki
    Honda, Kazunori
    Shimokata, Tomoya
    Ando, Yuichi
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (11) : 1331 - 1338
  • [5] Opioid-Induced Constipation
    Webster, Lynn R.
    PAIN MEDICINE, 2015, 16 : S16 - S21
  • [6] Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management
    Kumar, Lalit
    Barker, Chris
    Emmanuel, Anton
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [7] Management of opioid-induced constipation
    Thorpe D.M.
    Current Pain and Headache Reports, 2001, 5 (3) : 237 - 240
  • [8] Methylnaltrexone for opioid-induced constipation
    Belavic, Jennifer M.
    NURSE PRACTITIONER, 2009, 34 (03): : 6 - 7
  • [9] Management of Opioid-induced Constipation
    Johnson, David A.
    Argoff, Charles E.
    JOURNAL OF FAMILY PRACTICE, 2015, 64 (12): : S4 - S9
  • [10] Clinical utility of naloxegol in the treatment of opioid-induced constipation
    Bruner, Heather C.
    Atayee, Rabia S.
    Edmonds, Kyle P.
    Buckholz, Gary T.
    JOURNAL OF PAIN RESEARCH, 2015, 8 : 289 - 294